MDA and Targeted Control Against Plasmodium Carriage in the Sahel

NCT07281443 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

18000

Enrollment

OTHER_GOV

Sponsor class

Conditions

Malaria, Falciparum
Malaria, Asymptomatic Parasitaemia

Interventions

DRUG: MDA with DHAp and SLD Primaquine
BEHAVIORAL: Targeted control (10-24 years) during the malaria high tranmission season: behaviour
DIAGNOSTIC_TEST: Targeted control (15-24 years) during the malaria high tranmission season: test and treat

Sponsor

Institut de Recherche pour le Developpement

Collaborators

[object Object]
[object Object]
[object Object]